123 related articles for article (PubMed ID: 30838640)
1. tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas.
Kuang M; Zheng D; Tao X; Peng Y; Pan Y; Zheng S; Zhang Y; Li H; Yuan C; Zhang Y; Xiang J; Li Y; Chen H; Sun Y
Int J Cancer; 2019 Oct; 145(7):1982-1990. PubMed ID: 30838640
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
3. Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma.
Zheng R; Mao W; Du Z; Zhang J; Wang M; Hu M
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):377-382. PubMed ID: 30442364
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential prognostic long non‑coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
Wang X; Ding Y; Da B; Fei Y; Feng G
Oncol Rep; 2018 Dec; 40(6):3199-3212. PubMed ID: 30272355
[TBL] [Abstract][Full Text] [Related]
6. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.
Li S; Yang R; Sun X; Miao S; Lu T; Wang Y; Wo Y; Jiao W
Gene; 2018 Dec; 679():398-404. PubMed ID: 30240883
[TBL] [Abstract][Full Text] [Related]
7. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale analysis to identify prognostic markers and predict the survival of lung adenocarcinoma.
Li YY; Yang C; Zhou P; Zhang S; Yao Y; Li D
J Cell Biochem; 2018 Nov; 119(11):8909-8921. PubMed ID: 30105759
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
Liu L; Ni J; He X
Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma.
Yu J; Wang L; Zhang T; Shen H; Dong W; Ni Y; Du J
Tumour Biol; 2015 Aug; 36(8):6551-8. PubMed ID: 25820700
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
Cheng MW; Shen ZT; Hu GY; Luo LG
Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
[TBL] [Abstract][Full Text] [Related]
12. Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status.
Li H; Wang W; Jia H; Lian J; Cao J; Zhang X; Song X; Jia S; Li Z; Cao X; Zhou W; Han S; Yang W; Xi Y; Lian S
Thorac Cancer; 2017 Sep; 8(5):436-442. PubMed ID: 28597503
[TBL] [Abstract][Full Text] [Related]
13. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.
Qixing M; Juqing X; Yajing W; Gaochao D; Wenjie X; Run S; Anpeng W; Lin X; Feng J; Jun W
Tumour Biol; 2017 Apr; 39(4):1010428317698340. PubMed ID: 28381170
[TBL] [Abstract][Full Text] [Related]
14. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of transfer RNAs and their role as novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Heyns M; Li D; Mackey JR; Kovalchuk O; Damaraju S
Sci Rep; 2016 Sep; 6():32843. PubMed ID: 27604545
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma.
Wu Q; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH
Lung Cancer; 2012 Aug; 77(2):407-14. PubMed ID: 22542705
[TBL] [Abstract][Full Text] [Related]
18. Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression.
Zhou C; Wang Y; Wang Y; Lei L; Ji MH; Zhou G; Xia H; Yang JJ
Aging (Albany NY); 2021 Feb; 13(6):8706-8719. PubMed ID: 33619234
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
20. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
